West Pharmaceutical Services (WST) Current Assets (2009 - 2026)

West Pharmaceutical Services has disclosed Current Assets across 18 years of filings, most recently posting $1.8 billion for Q1 2026.

• Current Assets for Q1 2026 came in at $1.8 billion, up 25.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 25.34% YoY), and the FY2025 annual result was $2.0 billion, up 28.61% from the prior year.
• Current Assets came in at $1.8 billion for Q1 2026 at West Pharmaceutical Services, down from $2.0 billion in the prior quarter.
• In the past five years, Current Assets ranged from a high of $2.0 billion in Q4 2025 to a low of $1.5 billion in Q1 2025.
• The 5-year median for Current Assets is $1.8 billion (2022), against an average of $1.8 billion.
• Across the five-year window, Current Assets slipped 21.38% in 2024 and gained 28.61% in 2025, its largest moves.
• West Pharmaceutical Services' Current Assets stood at $1.9 billion in 2022, then gained by 0.88% to $1.9 billion in 2023, then declined by 20.57% to $1.5 billion in 2024, then increased by 28.61% to $2.0 billion in 2025, then retreated by 7.65% to $1.8 billion in 2026.
• The last three Current Assets figures came in at $1.8 billion (Q1 2026), $2.0 billion (Q4 2025), and $1.8 billion (Q3 2025), per Business Quant data.